Sponsor

Laboratorios Silanes S.A. de C.V.

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Laboratorios Silanes S.A. de C.V. appears in 15 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials15
Recruiting shown0
Roles1
SourceClinicalTrials.gov
Advertisement

Clinical trials

15 shown
Oral Combination of Glimepiride/Vildagliptin/Metformin in Patients With T2D and Dual Treatment FailureNCT04841096 · lead sponsor · 2023-03-21
COMPLETED
Efficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial HypertensionNCT04927299 · lead sponsor · 2022-06-30
COMPLETED
Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP.NCT04882293 · lead sponsor · 2022-02-15
UNKNOWN
Efficacy and Safety of Metformin Glycinate Compared to Metformin Hydrochloride on the Progression of Type 2 DiabetesNCT04943692 · lead sponsor · 2021-08-01
SUSPENDED
Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2NCT04626089 · lead sponsor · 2021-02-01
WITHDRAWN
Efficacy Study of Metformin Glycinate on Postprandial LipemiaNCT02064881 · lead sponsor · 2015-10-01
UNKNOWN
Metformin Glycinate on Metabolic Control and Inflammatory Mediators in Type 2 DiabetesNCT01386671 · lead sponsor · 2014-06-01
COMPLETED
Metformin vs Conjugated Linoleic Acid and an Intervention Program With Healthy Habits in Obese ChildrenNCT02063802 · lead sponsor · 2012-08-01
UNKNOWN
Study on DMMET-01 Versus Metformin on Improvement of Metabolic Control in Naive Type 2 Diabetes PatientsNCT00940472 · lead sponsor · 2009-03-01
COMPLETED
Effect of Oral Combination Therapy in a Single Dosage Form in Patients With Type 2 Diabetes MellitusNCT00941161 · lead sponsor · 2009-02-01
COMPLETED
Sibutramine-metformin Combination Versus Sibutramine and Metformin Monotherapy in Obese PatientsNCT00941382 · lead sponsor · 2008-11-01
UNKNOWN
Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients (CLAMP)NCT00940797 · lead sponsor · 2008-07-01
COMPLETED
Endothelial Disfunction Treatment With Glimepiride/Metformin Combination (Glimetal) in Type 2 Diabetes PatientsNCT01429818 · lead sponsor · 2007-07-01
COMPLETED
Gastric Tolerability and Pharmacokinetics of DMMET-01NCT00960882 · lead sponsor · 2007-06-01
COMPLETED
Fixed Dose Combination of Fluoxetin and Metformin in the Management of Overweight and ObesityNCT03051451 · lead sponsor
SUSPENDED

Drugs studied in this sponsor's trials

6 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Laboratorios Silanes S.A. de C.V. as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
metformin4
metformin hydrochloride4
placebo2
placebo Oral Tablet2
glimepiride1
sibutramine1

Sponsor roles

lead sponsor15
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.